Although PD-1+Vβ5.2+ and PD-1+Vβ12+ CD8+ T cells were thought to be related to poor prognosis in AML (17), our previous study found that clonally expanded TRDV T cells might benefit the immune response directed against AML (18). The gene discussed is CD8A; the disease is acute myeloid leukemia.